Live from the NIH registry
Studies recruiting near Fayetteville right now
Top 25 of 119 recruiting studies, sorted by proximity — each links to its official registry page
Study of Trastuzumab Deruxtecan Versus Standard of Care Chemotherapy for HER2-Expressing (IHC 3+/2+) Endometrial Cancer
Endometrial Cancer
Phase 3
Interventional 710 participants sought
FirstHealth of the Carolinas, Inc. — Pinehurst, North Carolina (28.8 mi)
· Sponsor: Daiichi Sankyo
Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)
Triple-Negative Breast Cancer
Phase 3
Interventional 1,530 participants sought
Cape Fear Valley Health System ( Site 0136) — Fayetteville, North Carolina (6.0 mi)
· Sponsor: Merck Sharp & Dohme LLC
A Study to Assess Adverse Events and How Intravenously (IV) Infused Telisotuzumab Vedotin (ABBV-399) Moves Through the Body as a Monotherapy in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC)
Non-Small Cell Lung Cancer
Phase 2
Interventional 150 participants sought
FirstHealth of the Carolinas- Speciality Center /ID# 272924 — Pinehurst, North Carolina (28.8 mi)
· Sponsor: AbbVie
Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention
Percutaneous Coronary Intervention, Peripheral Endovascular Intervention
Phase 4
Interventional 6,000 participants sought
Javara Inc. — Fayetteville, North Carolina (6.0 mi)
· Sponsor: Duke University
Scheduled or As Needed Pain Regimen?
Pain, Postoperative
Phase 4
Interventional 90 participants sought
Cape Fear Valley Medical Center — Fayetteville, North Carolina (6.0 mi)
· Sponsor: Cape Fear Valley Health System
A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer
Non-Small Cell Lung Cancer, KRAS G12C Lung Cancer
Phase 3
Interventional 600 participants sought
Firsthealth of The Carolinas — Pinehurst, North Carolina (28.8 mi)
· Sponsor: Hoffmann-La Roche
Prospective Non-Interventional Study Comparing Osimertinib +/- Chemotherapy for EGFR-Mutated NSCLC Patients
Non Small Cell Lung Cancer, Epidermal Growth Factor Receptor Gene Mutation
N/A
Observational 538 participants sought
FirstHealth of the Carolinas-Moore Regional Hospital — Pinehurst, North Carolina (28.8 mi)
· Sponsor: PrECOG, LLC.
Testing the Addition of Anti-Cancer Drug, Cetuximab, to Standard of Care Treatment (Pembrolizumab) for Returning or Spreading Head and Neck Cancer After Previous Treatment
Multiple conditions
Phase 3
Interventional 158 participants sought
FirstHealth of the Carolinas-Moore Regional Hospital — Pinehurst, North Carolina (28.8 mi)
· Sponsor: National Cancer Institute (NCI)
Treatment of Acute PTH With a CGRP Receptor mAb in Military Service Members and Civilians With mTBI
Posttraumatic Headache, Mild Traumatic Brain Injury
Phase 2
Interventional 404 participants sought
Womack Army Medical Center - Fort Liberty — Fort Bragg, North Carolina (4.1 mi)
· Sponsor: Henry M. Jackson Foundation for the Advancement of Military Medicine
Safety and Efficacy of Boric Acid Inserts for Treatment of Vulvovaginal Candidiasis
Vulvovaginal Candidiases, Vulvovaginal Candidiasis, Genital
Phase 3
Interventional 400 participants sought
Cross Creek Medical Clinic, PA — Fayetteville, North Carolina (6.0 mi)
· Sponsor: pH-D Feminine Health LLC
A Study of Nipocalimab in Adults With Moderate to Severe Systemic Lupus Erythematosus
Lupus Erythematosus, Systemic
Phase 3
Interventional 600 participants sought
Cross Creek Medical Clinic — Fayetteville, North Carolina (6.0 mi)
· Sponsor: Janssen Research & Development, LLC
Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
Ulcerative Colitis, Obesity or Overweight
Phase 3
Interventional 350 participants sought
Coastal Research Institute - Fayetteville — Fayetteville, North Carolina (6.0 mi)
· Sponsor: Eli Lilly and Company
Studying Chemotherapy With or Without Panitumumab for Unresectable, Locally Advanced, or Metastatic Pancreatic Cancer Without KRAS Mutations
Locally Advanced Pancreatic Adenocarcinoma, Metastatic Pancreatic Adenocarcinoma
Phase 3
Interventional 94 participants sought
FirstHealth of the Carolinas-Moore Regional Hospital — Pinehurst, North Carolina (28.8 mi)
· Sponsor: SWOG Cancer Research Network
Hydrus® Microstent New Enrollment Post-Approval Study
Primary Open Angle Glaucoma
N/A
Interventional 545 participants sought
Carolina Eye Associates PA — Southern Pines, North Carolina (24.2 mi)
· Sponsor: Alcon Research
Using Biomarker Tests to Select and Test New, Personalized Treatments for Extensive Stage Small Cell Lung Cancer, PRISM Study
Extensive Stage Lung Small Cell Carcinoma, Lung Small Cell Carcinoma, A Subtype
Phase 2
Interventional 900 participants sought
FirstHealth of the Carolinas-Moore Regional Hospital — Pinehurst, North Carolina (28.8 mi)
· Sponsor: SWOG Cancer Research Network
Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
Stage III Colon Cancer
Phase 2, Phase 3
Interventional 1,912 participants sought
FirstHealth of the Carolinas-Moore Regional Hospital — Pinehurst, North Carolina (28.8 mi)
· Sponsor: NRG Oncology
Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastatic Prostate Cancer, ASPIRE Trial
Castration-Sensitive Prostate Carcinoma, Metastatic Prostate Adenocarcinoma
Phase 3
Interventional 1,260 participants sought
FirstHealth of the Carolinas-Moore Regional Hospital — Pinehurst, North Carolina (28.8 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
Pre- and Post-neuromusculoskeletal Injury Risk Evaluation for Return-to-Duty Enhancement
Musculoskeletal Injuries
N/A
Observational 2,690 participants sought
Womack Army Medical Center — Fort Liberty, North Carolina (4.0 mi)
· Sponsor: Womack Army Medical Center
Ketamine, SGB and Combination Treatment for TBI-associated Headache or PTSD
Posttraumatic Headache, Posttraumatic Stress Disorder
Phase 2
Interventional 175 participants sought
Womack Army Medical Center — Fort Bragg, North Carolina (4.1 mi)
· Sponsor: Northwestern University
Effect of Dalcetrapib on CV Risk in a Genetically Defined Population With a Recent ACS
Acute Coronary Syndrome
Phase 3
Interventional 2,000 participants sought
Research Site — Pinehurst, North Carolina (28.8 mi)
· Sponsor: DalCor Pharmaceuticals
EXActDNA-003 / NSABP B-64: Study of Molecular Residual Disease Detection in Breast Cancer (MRD)
Breast Cancer
N/A
Observational 1,800 participants sought
FirstHealth Outpatient Cancer Center — Pinehurst, North Carolina (28.8 mi)
· Sponsor: Exact Sciences Corporation
Neurocognitive Ankle Training for Instability to Optimize Neuromusculoskeletal Outcomes (NATION)
Chronic Ankle Instability
N/A
Interventional 180 participants sought
Womack Army Medical Center — Fort Bragg, North Carolina (4.1 mi)
· Sponsor: Womack Army Medical Center
A Study to Assess Disease Activity and Adverse Events of Intravenous (IV) Telisotuzumab Vedotin Compared to IV Docetaxel in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC)
Non Small Cell Lung Cancer
Phase 3
Interventional 768 participants sought
FirstHealth of the Carolinas- Speciality Center /ID# 241279 — Pinehurst, North Carolina (28.8 mi)
· Sponsor: AbbVie
Adding Nivolumab to Usual Treatment for People With Advanced Stomach or Esophageal Cancer, PARAMUNE Trial
Advanced Esophageal Adenocarcinoma, Advanced Gastric Adenocarcinoma
Phase 2, Phase 3
Interventional 224 participants sought
FirstHealth of the Carolinas-Moore Regional Hospital — Pinehurst, North Carolina (28.8 mi)
· Sponsor: National Cancer Institute (NCI)
ERP to Improve Functioning in Veterans With OCD
Obsessive Compulsive Disorder (OCD), Comorbid Post-Traumatic Stress Disorder and OCD
N/A
Interventional 160 participants sought
Fayetteville VA Medical Center, Fayetteville, NC — Fayetteville, North Carolina (6.0 mi)
· Sponsor: VA Office of Research and Development